Undervalued Stocks for July 2025: Resurs Holding, Puyang Refractories Group, Medy-Tox, and More

Global stock markets have shown a muted response to new US tariffs, with the Nasdaq Composite Index demonstrating resilience amid declines in major US indexes. Investors can identify undervalued stocks with prices below their intrinsic value, especially during market volatility and uncertainty. The top 10 undervalued stocks based on cash flows include Resurs Holding, Puyang Refractories Group, Medy-Tox, and JRCLtd, among others.

Global stock markets have shown a muted response to new US tariffs, with the Nasdaq Composite Index demonstrating resilience amid declines in major US indexes. Despite the economic uncertainty and volatility, investors can identify undervalued stocks with prices below their intrinsic value, particularly during market fluctuations.

According to a recent analysis by Simply Wall St, several stocks are estimated to be undervalued by up to 27.5% based on cash flows. Among these, Bruker Corporation (BRKR), Natera, Inc. (NTRA), and Levi Strauss & Co. (LEVI) stand out as promising investment opportunities.

Bruker Corporation, with a market cap of approximately $6.38 billion, develops, manufactures, and distributes scientific instruments and analytical solutions. The company's revenue is primarily generated from its BSI CALID, BSI Nano, BSI BioSpin, and BEST segments. Bruker is trading at US$43.58, below its estimated fair value of US$49.22, suggesting it may be undervalued by 11.5% [1].

Natera, Inc., a diagnostics company offering molecular testing services globally, has a market cap of $22.09 billion. Natera generates $1.83 billion from its molecular testing services segment worldwide and is trading at US$163.36, below its estimated fair value of US$210.42, indicating a potential undervaluation of 22.4% [1].

Levi Strauss & Co., a global apparel company, has a market capitalization of approximately $7.67 billion. The company's revenue is primarily derived from its operations in the Americas, Europe, and Asia. Levi Strauss is priced at US$19.73, below its estimated fair value of US$27.2, highlighting potential undervaluation by 27.5% [1].

Investors should consider these undervalued stocks as opportunities to capitalize on market inefficiencies. However, it is essential to conduct thorough research and consider the risks associated with each investment.

References:
[1] https://finance.yahoo.com/news/3-stocks-estimated-undervalued-27-173753505.html